Medicine Man Technologies, Inc. Logo

Medicine Man Technologies, Inc.

SHWZ

(1.8)
Stock Price

0,11 USD

0.03% ROA

-51.92% ROE

-0.33x PER

Market Cap.

19.562.100,00 USD

185.58% DER

0% Yield

-34.12% NPM

Medicine Man Technologies, Inc. Stock Analysis

Medicine Man Technologies, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Medicine Man Technologies, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.25x), the stock offers substantial upside potential at a bargain price.

2 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

3 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-21.21%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-24.49%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 DER

The stock is burdened with a heavy load of debt (123%), making it financially unstable and potentially risky for investors.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Medicine Man Technologies, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Medicine Man Technologies, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Hold

Medicine Man Technologies, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Medicine Man Technologies, Inc. Revenue
Year Revenue Growth
2014 251.891
2015 835.777 69.86%
2016 631.456 -32.36%
2017 3.529.584 82.11%
2018 7.924.456 55.46%
2019 10.618.498 25.37%
2020 24.000.852 55.76%
2021 108.420.239 77.86%
2022 159.379.219 31.97%
2023 186.987.740 14.76%
2023 172.447.786 -8.43%
2024 172.942.992 0.29%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Medicine Man Technologies, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Medicine Man Technologies, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 193.146
2015 519.882 62.85%
2016 1.009.841 48.52%
2017 7.129.210 85.84%
2018 4.402.993 -61.92%
2019 16.466.092 73.26%
2020 29.677.305 44.52%
2021 38.944.528 23.8%
2022 64.163.559 39.3%
2023 50.057.824 -28.18%
2023 70.933.204 29.43%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Medicine Man Technologies, Inc. EBITDA
Year EBITDA Growth
2014 -25.066
2015 96.771 125.9%
2016 -1.120.703 108.63%
2017 -5.061.988 77.86%
2018 764.203 762.39%
2019 -9.467.444 108.07%
2020 -25.022.255 62.16%
2021 3.465.624 822.01%
2022 31.902.828 89.14%
2023 55.203.544 42.21%
2023 25.955.830 -112.68%
2024 17.176.320 -51.11%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Medicine Man Technologies, Inc. Gross Profit
Year Gross Profit Growth
2014 179.891
2015 626.032 71.26%
2016 169.274 -269.83%
2017 2.227.303 92.4%
2018 5.346.946 58.34%
2019 3.002.277 -78.1%
2020 6.774.366 55.68%
2021 49.353.694 86.27%
2022 85.029.798 41.96%
2023 85.751.852 0.84%
2023 48.565.451 -76.57%
2024 76.176.756 36.25%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Medicine Man Technologies, Inc. Net Profit
Year Net Profit Growth
2014 -29.954
2015 85.749 134.93%
2016 -1.464.273 105.86%
2017 -5.381.172 72.79%
2018 948.915 667.09%
2019 -16.975.742 105.59%
2020 -19.416.761 12.57%
2021 14.519.130 233.73%
2022 -18.467.615 178.62%
2023 -1.289.848 -1331.77%
2023 -34.549.344 96.27%
2024 -55.746.324 38.02%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Medicine Man Technologies, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 -1 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 -1 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Medicine Man Technologies, Inc. Free Cashflow
Year Free Cashflow Growth
2014 -205.490
2015 247.636 182.98%
2016 -752.321 132.92%
2017 -929.660 19.08%
2018 1.267.421 173.35%
2019 -7.754.203 116.34%
2020 -10.567.863 26.62%
2021 51.666.721 120.45%
2022 -3.417.113 1612%
2023 2.182.966 256.54%
2023 1.585.309 -37.7%
2024 -724.786 318.73%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Medicine Man Technologies, Inc. Operating Cashflow
Year Operating Cashflow Growth
2014 -205.490
2015 301.843 168.08%
2016 -741.477 140.71%
2017 -673.997 -10.01%
2018 1.287.460 152.35%
2019 -7.553.965 117.04%
2020 -9.799.690 22.92%
2021 57.334.386 117.09%
2022 11.394.467 -403.18%
2023 6.945.632 -64.05%
2023 12.200.963 43.07%
2024 -108.353 11360.38%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Medicine Man Technologies, Inc. Capital Expenditure
Year Capital Expenditure Growth
2014 0
2015 54.207 100%
2016 10.844 -399.88%
2017 255.663 95.76%
2018 20.039 -1175.83%
2019 200.238 89.99%
2020 768.173 73.93%
2021 5.667.665 86.45%
2022 14.811.580 61.73%
2023 4.762.666 -210.99%
2023 10.615.654 55.14%
2024 616.433 -1622.11%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Medicine Man Technologies, Inc. Equity
Year Equity Growth
2014 289.576
2015 455.050 36.36%
2016 -376.326 220.92%
2017 10.739.160 103.5%
2018 17.073.764 37.1%
2019 26.579.945 35.76%
2020 41.774.859 36.37%
2021 133.569.665 68.72%
2022 132.163.371 -1.06%
2023 119.291.888 -10.79%
2023 145.790.662 18.18%
2024 90.787.309 -60.58%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Medicine Man Technologies, Inc. Assets
Year Assets Growth
2014 312.403
2015 476.965 34.5%
2016 727.851 34.47%
2017 11.132.363 93.46%
2018 18.221.606 38.91%
2019 32.228.607 43.46%
2020 70.682.601 54.4%
2021 285.030.792 75.2%
2022 322.921.013 11.73%
2023 358.144.332 9.83%
2023 370.590.687 3.36%
2024 339.610.648 -9.12%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Medicine Man Technologies, Inc. Liabilities
Year Liabilities Growth
2014 22.827
2015 21.915 -4.16%
2016 1.104.177 98.02%
2017 393.203 -180.82%
2018 1.147.842 65.74%
2019 5.648.662 79.68%
2020 28.907.742 80.46%
2021 151.461.127 80.91%
2022 190.757.642 20.6%
2023 238.852.444 20.14%
2023 224.800.025 -6.25%
2024 248.823.339 9.65%

Medicine Man Technologies, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.21
Net Income per Share
-0.75
Price to Earning Ratio
-0.33x
Price To Sales Ratio
0.11x
POCF Ratio
3
PFCF Ratio
-13.29
Price to Book Ratio
0.22
EV to Sales
1.17
EV Over EBITDA
19.18
EV to Operating CashFlow
31.19
EV to FreeCashFlow
-139.63
Earnings Yield
-3.02
FreeCashFlow Yield
-0.08
Market Cap
0,02 Bil.
Enterprise Value
0,21 Bil.
Graham Number
4.42
Graham NetNet
-2.8

Income Statement Metrics

Net Income per Share
-0.75
Income Quality
-0.11
ROE
-0.52
Return On Assets
-0.18
Return On Capital Employed
-0.04
Net Income per EBT
1.43
EBT Per Ebit
3.84
Ebit per Revenue
-0.06
Effective Tax Rate
-0.43

Margins

Sales, General, & Administrative to Revenue
0.2
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.32
Operating Profit Margin
-0.06
Pretax Profit Margin
-0.24
Net Profit Margin
-0.34

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.08
Free CashFlow per Share
-0.02
Capex to Operating CashFlow
1.22
Capex to Revenue
0.05
Capex to Depreciation
0.37
Return on Invested Capital
-0.06
Return on Tangible Assets
0
Days Sales Outstanding
7.36
Days Payables Outstanding
23.18
Days of Inventory on Hand
76.54
Receivables Turnover
49.57
Payables Turnover
15.75
Inventory Turnover
4.77
Capex per Share
0.1

Balance Sheet

Cash per Share
0,16
Book Value per Share
1,15
Tangible Book Value per Share
-2815.05
Shareholders Equity per Share
1.15
Interest Debt per Share
-208.79
Debt to Equity
1.86
Debt to Assets
0.5
Net Debt to EBITDA
17.36
Current Ratio
0.54
Tangible Asset Value
-222,60 Bil.
Net Current Asset Value
-0,20 Bil.
Invested Capital
222711828474
Working Capital
-0,04 Bil.
Intangibles to Total Assets
655.71
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
25625042
Debt to Market Cap
8.61

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Medicine Man Technologies, Inc. Dividends
Year Dividends Growth

Medicine Man Technologies, Inc. Profile

About Medicine Man Technologies, Inc.

Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.

CEO
Mr. Forrest Hoffmaster
Employee
729
Address
4880 Havana Street
Denver, 80239

Medicine Man Technologies, Inc. Executives & BODs

Medicine Man Technologies, Inc. Executives & BODs
# Name Age
1 Mr. Forrest Hoffmaster
Interim Chief Executive Officer & Chief Financial Officer
70
2 Mr. Collin Lodge
President of Colorado Division
70
3 Mr. David Kaufman
Executive Vice President of Integrated Supply Chain
70
4 Mr. Daniel R. Pabon
Chief Policy & Regulatory Affairs Officer
70
5 Ms. Christine Jones
Chief Legal Officer & Corporate Secretary
70
6 Mr. Christopher Lee Driessen
Executive Vice President of Commercial Sales
70
7 Ed Eissenstat
Vice President of Information Technology & C.I.O
70
8 Rebecca Terry
Controller
70
9 Mr. Dan Bonach
Vice President of Human Resources
70
10 Mr. Todd Williams
Executive Vice President of M&A and Real Estate
70

Medicine Man Technologies, Inc. Competitors

Lowell Farms Inc. Logo
Lowell Farms Inc.

LOWLF

(1.2)
Columbia Care Inc. Logo
Columbia Care Inc.

CCHWF

(1.0)
Ayr Wellness Inc. Logo
Ayr Wellness Inc.

AYRWF

(1.5)
4Front Ventures Corp. Logo
4Front Ventures Corp.

FFNTF

(0.5)
Verano Holdings Corp. Logo
Verano Holdings Corp.

VRNOF

(1.0)